Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces, in partnership with the Colombia Cancer League, the launch of the “Cannabis: Medicine for Your Life” campaign throughout Colombia. In partnership with the Colombia Cancer League and 21 medical clinics throughout the country, chronic pain, palliative care and oncology patients (seeking to manage chemotherapy related sickness) will be able to access consultations for medical cannabis.
Alvaro Torres, CEO and Director comments, “We are very excited to be partnering with some of the country’s leading specialized medical institutions to increase awareness and provide safe access to patients seeking different types of treatments. As more external health care providers complete our medical cannabis education program, physician engagement and willingness to prescribe continues to improve, providing greater access to the more than two million patients that suffer from chronic pain in Colombia. In due course, we hope to expand the reach of these campaigns to include additional pathologies and more countries throughout the region.”
The campaign will be hosted in 11 Colombian cities in partnership with 21 participating clinics, which will be donating up to 3,000 medical consultations throughout the month of June. Consultations will be provided both in person and through teleconsultation channels. The campaign will be co-organized by Khiron and the Colombia Cancer League, a leading institution in the provision of oncology services, with 60 years of experience in the country.
Patients may schedule their consultation by dialing +57 333 0333191 or through the website www.cannabismedicinaparatuvida.com.
About Khiron Life Sciences Corp.
Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Colombia, Peru, Germany and the United Kingdom, and is positioned to commence sales in Mexico and Brazil in 2021.
Leveraging wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty. Its Wellbeing Products unit launched the first branded CBD skincare brand in Colombia, with Kuida™ now marketed in multiple jurisdictions in Latin America, the US and United Kingdom. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.